RISK FACTORS FOR CARDIOVASCULAR DISEASES (DEPRESSION, OVERWEIGHT/OBESITY) AND THE ROLE OF FTO GENE POLYMORPHISM IN THEIR COMORBIDITY AMONG 25–34 YEAR-OLD INDIVIDUALS
https://doi.org/10.17802/2306-1278-2024-13-4-13-23
Abstract
Highlights
Obesity and depression are a growing global public health problem affecting people of all ages and socioeconomic status. They are independently among the major risk factors for cardiovascular disease. In terms of biological mechanisms, genetic risk factors have been proposed as a potential factor associated with the comorbidity of depression and obesity. Significant correlations were found between the A/A rs9939609 genotype of the FTO gene and both depression and overweight/obesity compared to non-depressed and normal weight A/T+T/T genotypes in young individuals. Our findings will provide a useful starting point for understanding the biological mechanism involved in the association between obesity and depression in the population.
Abstract
Aim. To analyze the relationship between the rs9939609 T>A genotypes of the FTO gene, depression and overweight/obesity as risk factors for cardiovascular diseases among young people aged 25–34 residing in Novosibirsk.
Methods. The population-based study included Novosibirsk residents aged 25–34, the study was conducted in 2013–2016 within the framework of the research topic FWNR-2024-0002. 975 people (43.7% men, Caucasians) were screened, the response rate was 71%. Demographic and social data and anthropometry were collected. All study participants took the “MONICA-MOPSY” psychosocial questionnaire. Genotyping of the FTO gene polymorphism was carried out at the Research Institute of Therapeutic Microbiology and Microbiology, a branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk.
Results. The distribution of the A/A rs9939609 genotype of the FTO gene was higher in both the overweight (36.8%) and obese (45.6%) groups compared to the normal BMI group (17.5%). The distribution of the T/T genotypes was higher in the normal BMI group (51.6%) compared to the overweight (32%) and obese (16.4%) groups. The average BMI (body mass index) values were higher among carriers of the A/A genotype (30.4 ± 7.4 kg/m2) compared to carriers of the A/T (26.4 ± 5.2 kg/m2) and T/T (25.2 ± 5.2 kg/m2) genotypes (p < 0.001). The average depression scores were higher among carriers of the A/A genotype 4.4 ± 2.6, compared to carriers of the A/T genotype 3.1 ± 2.2 and T/T 2.9 ± 2.0 (p < 0.001). Carriage of the A/A genotype of the FTO gene was a predictor of both depression (OR = 3.267; 95% CI 1.770–6.030; p < 0.001) and overweight/obesity (OR = 2.208; 95% CI 1.228–9.777; p < 0.001) compared to carriers of the A/T+T/T genotypes without depression and with normal body weight.
Conclusion. The results established the role of the A/A rs9939609 polymorphism of the FTO gene in the comorbidity of depression and obesity.
About the Authors
Valery V. GafarovRussian Federation
PhD, Professor, Honored Scientist of the Russian Federation, Honored Veteran of the Siberian Branch of the Russian Academy of Sciences, Chief Researcher, Head of the Laboratory of Psychological and Sociological Problems of Therapeutic Diseases, Research Institute for Therapy and Preventive Medicine – branch of the Federal State Budgetary Scientific Institution “Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences”, Novosibirsk, Russian Federation
Elena A. Gromova
Russian Federation
PhD, Leading Researcher at the Laboratory of Psychological and Sociological Problems of Therapeutic Diseases, Research Institute for Therapy and Preventive Medicine – branch of the Federal State Budgetary Scientific Institution “Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences”, Novosibirsk, Russian Federation
Diana V. Denisova
Russian Federation
PhD, Honored Veteran of the Siberian Branch of the Russian Academy of Sciences, Chief Researcher at the Laboratory of Preventive Medicine, Research Institute for Therapy and Preventive Medicine – branch of the Federal State Budgetary Scientific Institution “Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences”, Novosibirsk, Russian Federation
Andrey V. Sukhanov
Russian Federation
PhD, Senior Researcher at the Laboratory of Psychological and Sociological Problems of Therapeutic Diseases, Research Institute for Therapy and Preventive Medicine – branch of the Federal State Budgetary Scientific Institution “Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences”, Novosibirsk, Russian Federation
Vladimir N. Maksimov
Russian Federation
PhD, Professor, Head of the Laboratory of Molecular Genetic Research, Research Institute for Therapy and Preventive Medicine – branch of the Federal State Budgetary Scientific Institution “Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences”, Novosibirsk, Russian Federation
Igor V. Gagulin
Russian Federation
Senior Researcher at the Laboratory of Psychological and Sociological Problems of Therapeutic Diseases, Research Institute for Therapy and Preventive Medicine – branch of the Federal State Budgetary Scientific Institution “Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences”, Novosibirsk, Russian Federation
Kristina V. Likhenko-Logvinenko
Russian Federation
Junior Researcher at the Laboratory of Psychological and Sociological Problems of Therapeutic Diseases, Research Institute for Therapy and Preventive Medicine – branch of the Federal State Budgetary Scientific Institution “Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences”, Novosibirsk, Russian Federation
Almira V. Gafarova
Russian Federation
PhD, Senior Researcher at the Laboratory of Psychological and Sociological Problems of Therapeutic Diseases, Research Institute for Therapy and Preventive Medicine – branch of the Federal State Budgetary Scientific Institution “Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences”", Novosibirsk, Russian Federation
Competing Interests:
нет
References
1. Zarza-Rebollo J.A., Molina E., Rivera M. The role of the FTO gene in the relationship between depression and obesity. A systematic review. Neurosci Biobehav Rev. 2021;127:630-637. doi: 10.1016/j.neubiorev.2021.05.013.
2. Apovian C.M.. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016;22(7 Suppl):s176-85.
3. Zhao Q., Han B., Xu Q., Wang T., Fang C., Li R, Zhang L, Pei Y. Proteome and genome integration analysis of obesity. Chin Med J (Engl). 2023;136(8):910-921. doi: 10.1097/CM9.0000000000002644.
4. Wray N.R., Ripke S., Mattheisen M., Trzaskowski M., Byrne E.M. Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50(5):668-681. doi: 10.1038/s41588-018-0090-3.
5. Amare A.T., Schubert K.O., Klingler-Hoffmann M., Cohen-Woods S., Baune B.T. The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies. Transl Psychiatry. 2017;7(1):e1007. doi: 10.1038/tp.2016.261.
6. Dina C., Meyre D., Gallina S., Durand E., Körner A., Jacobson P., Carlsson L.M., Kiess W., Vatin V., Lecoeur C., Delplanque J., Vaillant E., Pattou F., Ruiz J., Weill J., Levy-Marchal C., Horber F., Potoczna N., Hercberg S., Le Stunff C., Bougnères P., Kovacs P., Marre M., Balkau B., Cauchi S., Chèvre J.C., Froguel P. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39(6):724-6. doi: 10.1038/ng2048.
7. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., Perry J.R., Elliott K.S., Lango H., Rayner N.W., Shields B., Harries L.W., Barrett J.C., Ellard S., Groves C.J., Knight B., Patch A.M., Ness A.R., Ebrahim S., Lawlor D.A., Ring S.M., Ben-Shlomo Y., Jarvelin M.R., Sovio U., Bennett A.J., Melzer D., Ferrucci L., Loos R.J., Barroso I., Wareham N.J., Karpe F., Owen K.R., Cardon L.R., Walker M., Hitman G.A., Palmer C.N., Doney A.S., Morris A.D., Smith G.D., Hattersley A.T., McCarthy M.I. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889-94. doi: 10.1126/science.1141634.
8. Du T., Rao S., Wu L., Ye N., Liu Z., Hu H., Xiu J., Shen Y., Xu Q. An association study of the m6A genes with major depressive disorder in Chinese Han population. J Affect Disord. 2015;183:279-86. doi: 10.1016/j.jad.2015.05.025.
9. Dedov I.I., Mokrysheva N.G., Mel’nichenko G.A., Troshina E.A., Mazurina N.V., Ershova E.V., Komshilova K.A., Andreeva E.N., Anciferov M.B., Biryukova E.V., Bordan N.S., Vagapova G.R., Volkova A.R., Volkova N.I., Volynkina A.P., Dzgoeva F.H., Kiseleva T.P., Nejmark A.E., Romancova T.I., Ruyatkina L.A., Suplotova L.A., Halimov YU.SH., Yаshkov Yu.I. Obesity. Clinical guidelines. Consilium Medicum. 2021;23(4):311-25. doi:10.26442/20751753.2021.4.20 0832. (In Russian)
10. World Health Organization. MONICA Psychosocial Optional Study. Suggested Measurement Instruments. Copenhagen: WHO Regional Office for Europe; 1988
11. Sambrook J., Russel D.W. Purification of nucleic acids by extraction with phenol:chloroform. CSH Protoc.2006, 1, pdb.prot 4455, doi: 10.1101/pdb.prot4455.
12. Bühl A., Zöfel P. SPSS Version 10. Einführung in die moderne Datenanalyse unter Windows. Trebbin; 2005. 608 p.
13. Rodriguez S., Gaunt T.R., Day I.N. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol. 2009;169:505–514. doi: 10.1093/aje/kwn359.
14. Poobalan A., Aucott L. Obesity Among Young Adults in Developing Countries: A Systematic Overview. Curr Obes Rep. 2016;5(1):2-13. doi: 10.1007/s13679-016-0187-x.
15. de Wit L., Have M.T., Cuijpers P., de Graaf R. Body Mass Index and risk for onset of mood and anxiety disorders in the general population: Results from the Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2). BMC Psychiatry. 2022;22(1):522. doi: 10.1186/s12888-022-04077-w.
16. Bruffaerts R., Demyttenaere K., Vilagut G., Martinez M., Bonnewyn A., De Graaf R., Haro J.M., Bernert S., Angermeyer M.C., Brugha T., Roick C., Alonso J. The relation between body mass index, mental health, and functional disability: a European population perspective. Can J Psychiatry. 2008;53(10):679–688. doi: 10.1177/070674370805301007.
17. Scott K.M., Bruffaerts R., Simon G.E., Alonso J., Angermeyer M., de Girolamo G., Demyttenaere K., Gasquet I., Haro J.M., Karam E., Kessler R.C., Levinson D., Medina Mora M.E., Oakley Browne M.A., Ormel J., Villa J.P., Uda H., Von Korff M. Obesity and mental disorders in the general population: results from the world mental health surveys. Int J Obes (Lond). 2008;32(1):192–200. doi: 10.1038/sj.ijo.0803701.
18. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377–1396. doi: 10.1016/S0140-6736(16)30054-X.
19. Milaneschi Y., Simmons W.K., van Rossum E.F.C, Penninx B.W. Depression and obesity: evidence of shared biological mechanisms. Mol Psychiatry. 2019;24(1):18–33. doi: 10.1038/s41380-018-0017-5.
20. Penninx B.W., Milaneschi Y., Lamers F., Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med. 2013;15(11):129. doi: 10.1186/1741-7015-11-129.
21. Emery C.F., Fondow M.D., Schneider C.M., Christofi F.L, Hunt C., Busby A.K., Needleman B.J., Melvin W.S., Elsayed-Awad H.M. Gastric bypass surgery is associated with reduced inflammation and less depression: a preliminary investigation. Obes Surg. 2007;17(6):759–763. doi: 10.1007/s11695-007-9140-0
22. Rivera M., Locke A.E., Corre T., Czamara D., Wolf C., Ching-Lopez A., Milaneschi Y., Kloiber S., Cohen-Woods S., Rucker J., Aitchison K.J., Bergmann S., Boomsma D.I., Craddock N., Gill M., Holsboer F., Hottenga J.J., Korszun A., Kutalik Z., Lucae S., Maier W., Mors O., Müller-Myhsok B., Owen M.J., Penninx B.W.J.H., Preisig M., Rice J., Rietschel M., Tozzi F., Uher R., Vollenweider P., Waeber G., Willemsen G., Craig I.W., Farmer A.E., Lewis C.M., Breen G., McGuffin P. Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals. Br J Psychiatry. 2017;211(2):70-76. doi: 10.1192/bjp.bp.116.183475.
23. Samaan Z., Anand S.S., Zhang X., Desai D., Rivera M., Pare G., Thabane L., Xie C., Gerstein H., Engert J.C., Craig I., Cohen-Woods S., Mohan V., Diaz R., Wang X., Liu L., Corre T., Preisig M., Kutalik Z., Bergmann S., Vollenweider P., Waeber G., Yusuf S., Meyre D. The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression. Mol Psychiatry. 2013;18(12):1281-6. doi: 10.1038/mp.2012.160.
24. Annapoorna P.K., Iyer H., Parnaik T., Narasimhan H., Bhattacharya A., Kumar A. FTO: An Emerging Molecular Player in Neuropsychiatric Diseases. Neuroscience. 2019; 418:15-24. doi: 10.1016/j.neuroscience.2019.08.021.
25. Fernandes B.S., Williams L.M., Steiner J., Leboyer M., Carvalho A.F., Berk M. The new field of 'precision psychiatry'. BMC Med. 2017;15(1):80. doi: 10.1186/s12916-017-0849-x.
26. Denisova D.V., Gurazheva A.A., Maximov V.N. Associations of polymorphisms of
27. some genes with excessive weight in a population sample of young citizens of Novosibirsk. Ateroscleroz, 2021; 17 (4): 35–42. doi: 10.52727/2078-256Х-2021-17-4-35-42. (In Russian)
28. Farmer A., Korszun A., Owen M.J., Craddock N., Jones L., Jones I., Gray J., Williamson R.J., McGuffin P. Medical disorders in people with recurrent depression. Br J Psychiatry. 2008;192(5):351-5. doi: 10.1192/bjp.bp.107.038380.
29. Mazo G.E., Kibitov A.O. Mechanisms of formation comorbidity depression and obesity. V.M. Bekhterev Review of Psychiatry and Medical Psychology. 2018;(1):65-78]. (In Russian)
Supplementary files
Review
For citations:
Gafarov V.V., Gromova E.A., Denisova D.V., Sukhanov A.V., Maksimov V.N., Gagulin I.V., Likhenko-Logvinenko K.V., Gafarova A.V. RISK FACTORS FOR CARDIOVASCULAR DISEASES (DEPRESSION, OVERWEIGHT/OBESITY) AND THE ROLE OF FTO GENE POLYMORPHISM IN THEIR COMORBIDITY AMONG 25–34 YEAR-OLD INDIVIDUALS. Complex Issues of Cardiovascular Diseases. 2024;13(4):13-23. (In Russ.) https://doi.org/10.17802/2306-1278-2024-13-4-13-23